$GNPX
Genprex, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Austin, TX
GNPX chart
What traders are saying about $GNPX
Latest postsGenprex, Inc. news
- Genprex, Inc. (0A8I.L) Seasonal returns chart
Yahoo Finance UK ·
- Genprex presents data linking gene therapy to cellular maintenance
Investing.com ·
- Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress
Yahoo Finance ·
- Genprex's REQORSA gene therapy shows promise in...
Pluang ·
- Genprex Identifies TROP2 Biomarker for Reqorsa Treatment Response
TipRanks ·
- Low TROP2 expression linked to resistance to Ge...
Pluang ·
- Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer
Yahoo Finance ·
- Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
Yahoo Finance ·
- Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
Yahoo Finance ·
- Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
Yahoo Finance ·
- Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
Yahoo Finance ·
Genprex, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| Net income | -$16.2M | -$21.4M | -$30.9M | -$23.7M |
| Total assets (year end) | $10.2M | $4.1M | $10.7M | $25.1M |
| Cash and equivalents (year end) | $7.8M | $1.6M | $6.7M | $21.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Genprex, Inc.
- Ticker
- GNPX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Austin, TX
- Incorporated in
- TX
- Fiscal year end
- December 31
- SEC CIK
- 1595248
Frequently asked questions
What exchange is Genprex, Inc. listed on?
Genprex, Inc. trades on the Nasdaq under the ticker symbol GNPX.
What industry is Genprex, Inc. in?
Genprex, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Genprex, Inc. headquartered?
Genprex, Inc.'s business address on file with the SEC is in Austin, TX.
When does Genprex, Inc.'s fiscal year end?
Genprex, Inc.'s fiscal year ends on December 31.
How much revenue did Genprex, Inc. report?
Genprex, Inc. reported $0 in revenue for calendar year 2024, according to its SEC filings.